Wald A, Zeh J, Selke S, Ashley R L, Corey L
Department of Medicine, University of Washington, Seattle 98144, USA.
N Engl J Med. 1995 Sep 21;333(12):770-5. doi: 10.1056/NEJM199509213331205.
The frequency, pattern, and anatomical sites of subclinical shedding of herpes simplex virus (HSV) in the genital tract, along with factors that predict such shedding, have not been well characterized.
We studied prospectively the clinical and virologic course of genital herpes in 110 women. The women kept symptom diaries and provided daily samples from the vulva, cervix, and rectum for viral culture.
During a median follow-up of 105 days, subclinical shedding of virus was identified in 36 of 65 women (55 percent) with HSV type 2 (HSV-2), in 16 of 31 women (52 percent) with HSV type 1 (HSV-1) and HSV-2, and in 4 of 14 women (29 percent) with only HSV-1. Among women with genital HSV-2 infection, subclinical shedding occurred on a mean of 2 percent of the days. The mean duration of viral shedding during subclinical episodes was 1.5 days, as compared with 1.8 days during symptomatic episodes. HSV was isolated from several sites in the genital tract and rectum in 17 percent of subclinical episodes and 22 percent of symptomatic episodes. Half the episodes of subclinical shedding of HSV occurred within seven days of a symptomatic recurrence. The risk of subclinical shedding increased with the frequency of symptomatic recurrences. Subclinical shedding was more frequent among women with more than 12 recurrences per year than among those with no symptomatic recurrences (odds ratio, 3.3; 95 percent confidence interval, 1.4 to 7.9); it was also more frequent among women who had recently acquired genital herpes (odds ratio for women with HSV acquired in the past year as compared with those who had had the infection for a year or more, 1.85; 95 percent confidence interval, 1.1 to 3.1).
Among women with a history of genital herpes infection, subclinical shedding of HSV is common and accounts for nearly one third of the total days of reactivation of HSV infection in the genital tract. Women with frequent symptomatic recurrences also have frequent subclinical shedding and may be at high risk for transmitting HSV.
单纯疱疹病毒(HSV)在生殖道的亚临床排毒频率、模式和解剖部位,以及预测此类排毒的因素,尚未得到充分描述。
我们对110名女性的生殖器疱疹临床和病毒学病程进行了前瞻性研究。这些女性记录症状日记,并每天提供来自外阴、宫颈和直肠的样本用于病毒培养。
在中位随访105天期间,65名2型单纯疱疹病毒(HSV-2)感染女性中有36名(55%)出现病毒亚临床排毒,31名1型单纯疱疹病毒(HSV-1)和HSV-2感染女性中有16名(52%)出现亚临床排毒,仅感染HSV-1的14名女性中有4名(29%)出现亚临床排毒。在生殖器HSV-2感染女性中,亚临床排毒平均发生在2%的天数。亚临床发作期间病毒排毒的平均持续时间为1.5天,而有症状发作期间为- 1.8天。在17%的亚临床发作和22%的有症状发作中,从生殖道和直肠的多个部位分离出HSV。HSV亚临床排毒发作的一半发生在有症状复发的7天内。亚临床排毒风险随有症状复发频率增加而升高。每年复发超过12次的女性比亚临床无复发的女性亚临床排毒更频繁(优势比,3.3;95%置信区间,1.4至7.9);近期感染生殖器疱疹的女性亚临床排毒也更频繁(过去一年感染HSV的女性与感染一年或更长时间的女性相比,优势比为1.85;95%置信区间,1.1至3.1)。
在有生殖器疱疹感染史的女性中,HSV亚临床排毒很常见,占生殖道HSV感染再激活总天数的近三分之一。有频繁有症状复发的女性也有频繁的亚临床排毒,可能有较高的HSV传播风险。